Federated Hermes’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
Federated Hermes's CRDF Position: Q2 2026 in Review
Federated Hermes increased its Cardiff Oncology (CRDF) stake by 114% in Q2 2026, buying an estimated $4.06K and bringing the position to 4,811 shares worth $6.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1889.
Federated Hermes first reported a position in CRDF in Q1 2022 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Federated Hermes held 4,811 shares of Cardiff Oncology worth $6.25K as of Q2 2026.
- Federated Hermes bought 2,558 Cardiff Oncology shares in Q2 2026, an estimated $4.06K.
- Cardiff Oncology made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1889 holding.
- Federated Hermes first reported a position in Cardiff Oncology in Q1 2022 and has held it in 4 quarters since.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.